rss Posted March 7, 2014 Report Share Posted March 7, 2014 Related ArticlesClinical effects of a novel topical composition on persistent redness observed in patients who had been successfully treated with topical or oral therapy for papulopustular rosacea. J Drugs Dermatol. 2014 Mar 1;13(3):326-31 Authors: Baldwin H, Berson D, Vitale M, Yatskayer M, Chen N, Oresajo C Abstract Rosacea is a condition most commonly characterized by central facial erythema and pupulopustules. There are highly effective drugs, both oral and topical, for papulopustular disease. At the present time, consistently effective pharmacologic therapy for erythematotelangiectatic rosacea is lacking. Patients whose papulopustular disease has been adequately treated are often still bothered by central facial erythema for which there is no adequate treatment short of laser and light. We present a study utilizing a novel topical composition evaluated for its ability to reduce background erythema remaining after adequate care of papulopustular disease. Patient, investigator and photographic evidence of erythema reduction was seen in 24/25 patients in this 8-week study.<BR /><BR /> <EM>J Drugs Dermatol.</EM> 2014;13(3):326-331. PMID: 24595579 [PubMed - in process] http://www.ncbi.nlm.nih.gov/pubmed/24595579?dopt=Abstract = URL to article Link to comment Share on other sites More sharing options...
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!Register a new account
Already have an account? Sign in here.Sign In Now